Access and activism: the ethics of providing antiretroviral therapy in developing countries
- 1 January 2001
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15, S81-S90
- https://doi.org/10.1097/00002030-200100005-00011
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Clinical Presentation and Risk Behaviors of Patients with Acquired Immunodeficiency Syndrome in Thailand, 1994-1998: Regional Variation and Temporal TrendsClinical Infectious Diseases, 2001
- World trade rules and cheaper drugsThe Lancet, 2001
- Access to fluconazole in less-developed countriesThe Lancet, 2000
- Impact of New Developments in Antiretroviral Treatment on AIDS Prevention and Care in Resource-Poor CountriesAIDS Patient Care and STDs, 2000
- AIDS activists in Thailand pressurise US governmentBMJ, 2000
- The New Drug Approvals of 1996, 1997, and 1998: Drug Development Trends in the User Fee EraDrug Information Journal, 2000
- Agencies urge end to global trade restrictions on essential medicinesBMJ, 1999
- Sleep less in SeattleThe Lancet, 1999
- Global trade and access to medicines: AIDS treatments in ThailandThe Lancet, 1999
- Globalization, Pharmaceutical Pricing, and South African Health Policy: Managing Confrontation with U.S. Firms and PoliticiansInternational Journal of Health Services, 1999